GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » resTORbio Inc (NAS:TORC) » Definitions » Interest Expense

resTORbio (resTORbio) Interest Expense : $0.00 Mil (TTM As of Jun. 2020)


View and export this data going back to 2018. Start your Free Trial

What is resTORbio Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. resTORbio's interest expense for the three months ended in Jun. 2020 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2020 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. resTORbio's Operating Income for the three months ended in Jun. 2020 was $ -5.65 Mil. resTORbio's Interest Expense for the three months ended in Jun. 2020 was $ 0.00 Mil. resTORbio has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.


resTORbio Interest Expense Historical Data

The historical data trend for resTORbio's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

resTORbio Interest Expense Chart

resTORbio Annual Data
Trend Dec16 Dec17 Dec18 Dec19
Interest Expense
- - - -

resTORbio Quarterly Data
Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

resTORbio Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


resTORbio  (NAS:TORC) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

resTORbio's Interest Expense for the three months ended in Jun. 2020 was $0.00 Mil. Its Operating Income for the three months ended in Jun. 2020 was $-5.65 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2020 was $0.00 Mil.

resTORbio's Interest Coverage for the quarter that ended in Jun. 2020 is calculated as

resTORbio had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


resTORbio (resTORbio) Business Description

Traded in Other Exchanges
N/A
Address
500 Boylston Street, 13th Floor, Boston, MA, USA, 02116
resTORbio Inc is a clinical-stage biopharmaceutical company. It mainly focuses on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. The company focuses on the mechanistic target of rapamycin (mTOR) pathway which regulates aging, and specifically on selective inhibition of the target of rapamycin complex 1. It is also involved in the development of RTB101 which is a small molecule, potent TORC1 inhibitor. The company's pipeline products include RTB101 and RTB101+ everolimus.

resTORbio (resTORbio) Headlines

From GuruFocus